About Raymond Martz
Form D filings for Adaptive Phage Therapeutics from 2019 to 2023 list Raymond Martz as director.
Raymond Martz first appears on SEC filings in 2019.
Experience
This experience comes from SEC filings. The years are when the filings name Raymond Martz in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Raymond Martz works with at each company, as listed on that company's latest Form D.
Adaptive Phage Therapeutics, Inc. · Form D, Jun 9, 2023
JL
Jonathan Leff
Director
JJ
Jana Jensen
Director
CM
Carl Merril
Director
IH
Ian Hardy
Director
MO
Michael Orndorff
Executive officer
GM
Gregory Merril
Chief Executive Officer and director
JG
Jesse Goodman
Director
MH
Martin Heidecker
Director
EL
Evan Loh
Director
SB
Subhendu Basu
Executive officer